- Home
- CMPS vs AFRI Comparison
CMPS vs AFRI Comparison
Compare CMPS & AFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPS
- AFRI
- Stock Information
- Founded
- CMPS 2020
- AFRI 1943
- Country
- CMPS United Kingdom
- AFRI Gibraltar
- Employees
- CMPS N/A
- AFRI N/A
- Industry
- CMPS Biotechnology: Pharmaceutical Preparations
- AFRI Packaged Foods
- Sector
- CMPS Health Care
- AFRI Consumer Staples
- Exchange
- CMPS Nasdaq
- AFRI Nasdaq
- Market Cap
- CMPS 280.2M
- AFRI 269.6M
- IPO Year
- CMPS 2020
- AFRI N/A
- Fundamental
- Price
- CMPS $4.09
- AFRI $10.30
- Analyst Decision
- CMPS Strong Buy
- AFRI
- Analyst Count
- CMPS 6
- AFRI 0
- Target Price
- CMPS $33.60
- AFRI N/A
- AVG Volume (30 Days)
- CMPS 666.3K
- AFRI 10.1K
- Earning Date
- CMPS 10-31-2024
- AFRI 01-07-2025
- Dividend Yield
- CMPS N/A
- AFRI N/A
- EPS Growth
- CMPS N/A
- AFRI N/A
- EPS
- CMPS N/A
- AFRI N/A
- Revenue
- CMPS N/A
- AFRI $305,476,000.00
- Revenue This Year
- CMPS N/A
- AFRI N/A
- Revenue Next Year
- CMPS N/A
- AFRI N/A
- P/E Ratio
- CMPS N/A
- AFRI N/A
- Revenue Growth
- CMPS N/A
- AFRI 5.42
- 52 Week Low
- CMPS $3.86
- AFRI $9.63
- 52 Week High
- CMPS $12.75
- AFRI $12.00
- Technical
- Relative Strength Index (RSI)
- CMPS 35.91
- AFRI 47.77
- Support Level
- CMPS $3.86
- AFRI $10.00
- Resistance Level
- CMPS $4.20
- AFRI $10.75
- Average True Range (ATR)
- CMPS 0.28
- AFRI 0.21
- MACD
- CMPS 0.00
- AFRI 0.03
- Stochastic Oscillator
- CMPS 8.06
- AFRI 21.33
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
About AFRI Forafric Global PLC
Forafric Global PLC is engaged in production and sale of a variety of wheat flours, Semolina and Pasta and Couscous in Morocco and in more than 45 countries. The two main brands in Morocco are MAYMOUNA and TRIA. The company derives majority of its revenue from Soft wheat.